COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

Documento (227.7Kb)
application/pdf
application/pdf
Date
2022Author(s)
Putman, M.
Kennedy, K.
Sirotich, E.
Liew, J.W.
Sattui, S.E.
Moni, T.T.
Akpabio, A.A.
Alpizar-Rodriguez, D.
Angevare, S.
Beesley, R.P.
Berenbaum, F.
Bulina, I.
Chock, Y.P.E.
Conway, R.
Duarte-García, A.
Singh, A.D.
Duff, E.
Durrant, K.L.
Gheita, T.A.
Hill, C.L.
Howard, R.
Hoyer, B.F.
Hsieh, E.
el Kibbi, L.
Kilian, A.
Kim, A.H.J.
Liew, D.F.L.
Lo, C.
Mateus, E.F.
Miller, B.
Mingolla, S.
Nudel, M.
Singh, J.A.
Singh, N.
Ugarte-Gil, M.F.
Wallace, J.
Young, K.J.
Zamora-Tehozol, E.A.
Bhana, S.
Costello, W.
Grainger, R.
Machado, P.M.
Robinson, P.C.
Sufka, P.
Wallace, Z.S.
Yazdany, J.
Harrison, C.
Larché, M.J.
Levine, M.
Foster, G.
Thabane, L.
Hausmann, J.S.
Sparks, J.A.
Simard, J.F.
Metadata
Show full item recordAbstract
As access to safe and effective COVID-19 vaccinations expands, vaccine hesitancy among people with rheumatic diseases has become increasingly important.1,2 Before widespread vaccination programmes, potential side-effects and flares after COVID-19 vaccination were frequent reasons for vaccine hesitancy among people with rheumatic disease.3,4 The study objective was to describe the perceptions and behaviours of people with rheumatic disease regarding COVID-19 vaccination and to identify the information sources most likely to affect their intention to be vaccinated...
